comparemela.com
Home
Live Updates
Moleculin Engages Wolfram C. M. Dempke, MD, PhD, MBA as its European Chief Medical Officer : comparemela.com
Moleculin Engages Wolfram C. M. Dempke, MD, PhD, MBA as its European Chief Medical Officer
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug...
Related Keywords
Germany ,
Bochum ,
Nordrhein Westfalen ,
Houston ,
Texas ,
United States ,
Munich ,
Bayern ,
Switzerland ,
Jenene Thomas ,
Walter Klemp ,
Wolframcm Dempke ,
Incyte Biosciences ,
Bristol Myers Squibb ,
Munich University Medical Oncology Department ,
Global Medical Affairs ,
Kyowa Kirin Pharmaceutical Development Ltd ,
Moleculin Biotech Inc ,
Linkedin ,
Twitter ,
Nasdaq ,
Facebook ,
Prnewswire Moleculin Biotech Inc ,
Expert At Novartis Oncology Global Clinical Development ,
Elbland Clinic Holding ,
Head Of The Department Haematology ,
University Of Halle ,
Scientific Solutions ,
Exchange Commission ,
Securities Exchange ,
Medical Officer ,
Vice President ,
Worldwide Clinical ,
Munich University Medical Oncology ,
Chief Executive Officer ,
External Expert ,
Novartis Oncology Global Clinical Development ,
Global Clinical Development ,
Executive Medical Director ,
Global Clinical Lead ,
Global Medical Oncology ,
Global Medical Affairs Oncology ,
Lead Medical Science Manager Oncology ,
Medical Oncology Department ,
General Hospital Goch ,
Deputy Head ,
Acting Representative ,
Medical Clinic ,
Haematology Departments ,
Elisabeth Hospital ,
Moleculin Biotech ,
Transcription Modulator ,
Securities Act ,
Securities Exchange Act ,
Private Securities Litigation Reform Act ,
Nc ,
comparemela.com © 2020. All Rights Reserved.